Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects.
Robbins
Mike E
ME
Department of Radiation Oncology, Brain Tumor Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. mrobbins@wfubmc.edu
Diz
Debra I
DI
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001921:Brain / Q000528:radiation effects; D002216:Captopril / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D007668:Kidney / Q000528:radiation effects; D008168:Lung / Q000528:radiation effects; D009249:NADP / Q000378:metabolism; D009369:Neoplasms / Q000532:radiotherapy; D018384:Oxidative Stress / Q000502:physiology; D011832:Radiation Injuries / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D017564:Radiation Pneumonitis / Q000517:prevention & control / Q000628:therapy; D017382:Reactive Oxygen Species / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000502:physiology*; D017741:Survivors
D000806:Angiotensin-Converting Enzyme Inhibitors; D017382:Reactive Oxygen Species; D000804:Angiotensin II; D009249:NADP; D002216:Captopril